SCHEMBL1161576

SCHEMBL1161576

ClCc1ccc2cnccc2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
IMPDH2 P12268 3/20 0.35
HDAC1 Q13547 2/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
PDE10A Q9Y233 2/20 0.33
CTSA P10619 2/20 0.33
MALT1 Q9UDY8 1/20 0.32
ROCK2 O75116 1/20 0.31
MELK Q14680 1/20 0.31
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
PKM P14618 1/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HDAC3 O15379 1/20 0.31
HDAC2 Q92769 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23554874 0.80 CCR1 (0.48) HDAC1HDAC6HDAC5PDE10ACTSA
SCHEMBL29550107 0.80 CCR1 (0.48) HDAC1HDAC6HDAC5PDE10ACTSA
SCHEMBL10271357 0.80 HDAC1 (0.36) PDE3BPDE3AIMPDH2HDAC1HDAC6
SCHEMBL14911919 0.78 PDE10A (0.38) HDAC1HDAC6HDAC5PDE10ACTSA
SCHEMBL28022103 0.74 KCNH2 (0.42) HDAC1PDE10ANPC1ALDH1A1RAB9A
Hydrochloric Acid SCHEMBL17395656 0.73 CYSLTR1 (0.50) PDE10AKDM4ENPC1ALDH1A1HPGD
SCHEMBL498405 0.72 CYSLTR1 (0.53) PDE10A
SCHEMBL29353900 0.72 CYSLTR1 (0.53) PDE10A
SCHEMBL3064494 0.72 IMPDH2 (0.42) PDE3BPDE3AIMPDH2CTSAMALT1
SCHEMBL30695314 0.72 IMPDH2 (0.42) PDE3BPDE3AIMPDH2CTSAMALT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011012622-A1 BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF GLYTL MEDIATED DISORDERS GLAXO GROUP LIMITED (GB) 2011-02-03 WO disclosed
WO-2011012622-A1 BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF GLYTL MEDIATED DISORDERS GLAXO GROUP LIMITED (GB) 2011-02-03 WO disclosed
US-5273980-A Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis MERCK FROSST CANADA INC. (CA) 1993-12-28 US disclosed
EP-0535924-A1 (Bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis MERCK FROSST CANADA INC. (CA) 1993-04-07 EP disclosed